Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Terminated 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 12Gynecologic 4Sarcoma 2Thoracic 1Lymphoid 1

Conditions

Sarcoma 2

Interventions

Radiotherapy 216Cyclophosphamide 211Doxorubicin 207Temozolomide 181Ifosfamide 121Filgrastim 111Etoposide 101Imatinib Mesylate 99Vincristine 92Gemcitabine 89Bevacizumab 83Magnetic Resonance Spectroscopy 79Irinotecan 79pembrolizumab 75Radiation 67Carboplatin 65pazopanib 60Methotrexate 60Nivolumab 58Cisplatin 58fludarabine phosphate 56Peripheral Blood Stem Cell Transplantation 56Specimen Handling 53Docetaxel 50Busulfan 48Trabectedin 47Biopsy 47Melphalan 46Surgical Procedures, Operative 45Paclitaxel 44

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Enhanced Recovery After Surgery × Sarcoma × Clear all
NCT04461171 2024-07-30

Enhanced Recovery After Surgery in Extremity Sarcoma

Vanderbilt-Ingram Cancer Center

Phase NA Recruiting
120 enrolled
Sarcoma

Sarcoma

NCT03916796 2022-04-12

Rehabilitation and Quality of Life Assessment for Soft Tissue Sarcoma Treated With Radiotherapy and Surgery

Washington University School of Medicine

Phase NA Terminated
10 enrolled
Sarcoma

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡